Anogenital Warts (HPV)

Overview

Plain-Language Overview

Anogenital warts (HPV) are small growths that appear on the skin or mucous membranes around the genital and anal areas. They are caused by an infection with the human papillomavirus (HPV), which affects the skin and mucous membranes. These warts can vary in size and shape, often appearing as soft, flesh-colored bumps or cauliflower-like clusters. The condition primarily involves the skin and mucosal surfaces of the anogenital region. While usually painless, the warts can cause discomfort, itching, or bleeding. The infection is spread through sexual contact, making it a common sexually transmitted condition. The presence of these warts can affect a person's quality of life and may require medical evaluation.

Clinical Definition

Anogenital warts (HPV) are benign epithelial proliferations caused by infection with low-risk types of human papillomavirus, primarily types 6 and 11. The virus infects the basal layer of the anogenital epithelium, leading to hyperplasia and the characteristic exophytic lesions. These warts represent a manifestation of cutaneous and mucosal HPV infection and are the most common clinical presentation of HPV in the anogenital region. Although generally benign, they are clinically significant due to their potential for recurrence, transmission, and association with other HPV-related diseases. The lesions can be found on the vulva, penis, perianal area, and sometimes the urethra or cervix. Diagnosis is important to differentiate from other anogenital lesions and to guide management. The presence of warts indicates active viral replication and infectivity.

Inciting Event

Sexual contact with an HPV-infected partner is the primary inciting event.
Microabrasions in the anogenital mucosa facilitate viral entry into basal keratinocytes.

Latency Period

The latency period from HPV exposure to wart appearance ranges from weeks to months, typically 3 weeks to 8 months.
Some infections remain subclinical or latent for years before lesion development.

Diagnostic Delay

Warts may be misdiagnosed as other anogenital lesions such as molluscum contagiosum or seborrheic keratosis.
Patients may delay seeking care due to asymptomatic or minimally symptomatic lesions.
Lack of awareness about HPV-related lesions can lead to missed diagnosis by clinicians.

Clinical Presentation

Signs & Symptoms

Asymptomatic in many cases, with warts discovered incidentally during exam.
Pruritus or mild discomfort localized to the wart area.
Bleeding or irritation if lesions are traumatized or inflamed.
Occasional pain if warts become large or ulcerated.
Psychosocial distress due to cosmetic concerns or stigma.

History of Present Illness

Patients report painless, flesh-colored or verrucous papules in the anogenital area that may coalesce into larger plaques.
Lesions often have a gradual onset and slow progression over weeks to months.
Some patients experience pruritus, bleeding, or discomfort especially if lesions are traumatized.

Past Medical History

History of prior HPV infection or anogenital warts increases risk of recurrence.
Immunosuppressive conditions such as HIV/AIDS or organ transplantation are relevant.
Lack of prior HPV vaccination is a notable risk factor.

Family History

There is no significant hereditary pattern for anogenital warts as HPV infection is acquired.
Family members may share risk factors such as sexual behaviors but not genetic predisposition.

Physical Exam Findings

Multiple flesh-colored, verrucous papules or plaques localized to the anogenital region.
Lesions often have a cauliflower-like surface and may coalesce into larger masses.
Warts are typically non-tender but can be friable and bleed if traumatized.
Lesions may be found on the penis, vulva, perianal skin, or cervix depending on exposure.
Occasionally, urethral or vaginal warts can be visualized on careful examination.

Diagnostic Workup

Diagnostic Criteria

Diagnosis of anogenital warts is primarily clinical, based on the presence of characteristic exophytic, papillomatous lesions in the anogenital region. Visualization of typical flesh-colored or hyperpigmented papules or plaques with a verrucous or cauliflower-like surface is diagnostic. Acetic acid application may be used to highlight lesions by causing whitening of affected epithelium. Histopathology from biopsy, showing koilocytosis and papillomatosis, can confirm diagnosis in uncertain cases. HPV typing is not routinely required but can be performed for epidemiologic or research purposes.

Pathophysiology

Key Mechanisms

Infection of basal keratinocytes by low-risk human papillomavirus (HPV) types 6 and 11 leads to viral DNA integration and expression of early proteins E6 and E7 that promote cell proliferation.
Epithelial hyperplasia results in the formation of characteristic exophytic, papillomatous lesions in the anogenital region.
Immune evasion by HPV allows persistent infection and lesion growth due to limited local immune response activation.
Koilocytosis (perinuclear clearing and nuclear atypia) in infected epithelial cells is a hallmark of HPV cytopathic effect.

Involvement	Details
Organs	Anus is a common site for HPV-induced wart formation due to mucocutaneous junction susceptibility
Organs	External genitalia including vulva, penis, and perineum are frequently affected by anogenital warts
Tissues	Epithelial tissue of the anogenital region is the site of HPV infection and wart development
Tissues	Stratified squamous epithelium undergoes hyperplasia and papillomatosis in wart lesions
Cells	Keratinocytes are the primary infected cells by HPV leading to wart formation through viral replication
	Langerhans cells participate in antigen presentation and local immune response against HPV-infected cells
	CD8+ T cells mediate cytotoxic immune clearance of HPV-infected keratinocytes
Chemical Mediators	Interferon-alpha is produced locally to enhance antiviral immunity against HPV
	Tumor necrosis factor-alpha (TNF-α) contributes to inflammation and wart regression
	Interleukin-12 (IL-12) promotes Th1 immune response critical for viral clearance

Treatments

Pharmacological Treatments

Imiquimod
- Mechanism:
  - Stimulates local immune response via TLR7 agonism to enhance antiviral activity against HPV-infected cells
- Side effects:
  - Local skin irritation
  - Erythema
  - Pruritus
- Clinical role:
  - First-line
Podophyllotoxin
- Mechanism:
  - Inhibits microtubule assembly causing mitotic arrest and necrosis of wart tissue
- Side effects:
  - Local irritation
  - Ulceration
  - Pain
- Clinical role:
  - First-line
Sinecatechins
- Mechanism:
  - Exerts antiviral and immunomodulatory effects through green tea catechins to clear warts
- Side effects:
  - Local erythema
  - Pruritus
  - Burning sensation
- Clinical role:
  - Second-line
Trichloroacetic acid (TCA)
- Mechanism:
  - Caustic agent causing chemical coagulation and destruction of wart tissue
- Side effects:
  - Local pain
  - Ulceration
  - Scarring
- Clinical role:
  - Second-line

Non-pharmacological Treatments

Cryotherapy with liquid nitrogen to induce tissue necrosis and wart destruction
Surgical excision for large or refractory warts to physically remove lesions
Laser therapy to ablate wart tissue using focused light energy
Electrocautery to destroy warts by thermal coagulation

Prevention

Pharmacological Prevention

Prophylactic HPV vaccination with quadrivalent or nonavalent vaccines targeting HPV 6, 11, 16, and 18.
Vaccination is recommended before sexual debut to maximize efficacy.
No antiviral medications currently prevent initial HPV infection.

Non-pharmacological Prevention

Consistent condom use reduces but does not eliminate HPV transmission risk.
Limiting number of sexual partners decreases exposure to HPV.
Regular cervical cancer screening with Pap smears and HPV testing in women.
Education on safe sexual practices to reduce HPV and other STI transmission.

Outcome & Complications

Complications

Secondary bacterial infection of warts due to excoriation or trauma.
Malignant transformation to squamous cell carcinoma in persistent high-risk HPV infections.
Obstruction of the urethra or anal canal by large wart masses.
Psychological impact including anxiety and reduced quality of life.

Short-term Sequelae	Long-term Sequelae
Wart growth and spread to adjacent anogenital skin areas. Local inflammation causing erythema and tenderness. Recurrence after treatment due to viral persistence in basal epithelium.	Chronic infection with recurrent warts over years. Increased risk of anogenital cancers especially with high-risk HPV types. Scarring or pigmentary changes after repeated treatments or large lesions. Persistent psychosocial distress related to chronic disease and stigma.

Differential Diagnoses

Anogenital Warts (HPV) versus Condyloma lata (secondary syphilis)

Anogenital Warts (HPV)	Condyloma lata (secondary syphilis)
Raised, verrucous, flesh-colored papules or plaques	Flat, broad, moist, grayish plaques
Caused by human papillomavirus (HPV), mainly types 6 and 11	Caused by Treponema pallidum
HPV DNA detection by PCR or characteristic histopathology	Positive non-treponemal and treponemal serologic tests

Anogenital Warts (HPV) versus Molluscum contagiosum

Anogenital Warts (HPV)	Molluscum contagiosum
Larger, cauliflower-like, verrucous papules without central umbilication	Small, dome-shaped, pearly papules with central umbilication
Caused by human papillomavirus (HPV)	Caused by molluscum contagiosum virus (poxvirus)
Common in sexually active adults	Common in children and immunocompromised adults

Anogenital Warts (HPV) versus Herpes simplex virus (HSV) infection

Anogenital Warts (HPV)	Herpes simplex virus (HSV) infection
Painless, verrucous papules or plaques	Painful grouped vesicles on an erythematous base
Chronic, slowly growing warty lesions	Recurrent painful outbreaks with vesicles and ulcers
HPV DNA detection or histopathology showing koilocytes	Positive HSV PCR or viral culture from vesicular fluid

Anogenital Warts (HPV) versus Lichen planus

Anogenital Warts (HPV)	Lichen planus
Flesh-colored, verrucous papules without Wickham striae	Flat-topped, violaceous, polygonal papules with Wickham striae
Viral-induced epithelial proliferation	T-cell mediated autoimmune reaction
Histopathology shows koilocytosis and papillomatosis	Histopathology shows sawtooth lymphocytic infiltrate at dermoepidermal junction

Anogenital Warts (HPV) versus Bowenoid papulosis

Anogenital Warts (HPV)	Bowenoid papulosis
Flesh-colored, verrucous papules	Multiple reddish-brown papules with possible erosion
Histology shows koilocytosis without full-thickness atypia	Histology shows full-thickness epidermal atypia (carcinoma in situ)
Associated with low-risk HPV types (6, 11)	Associated with high-risk HPV types (16, 18)